Study design and population: COVE mRNA-1273 vaccine trial
DISEASE
Details of the COVE trial through the end of the blinded phase are published elsewhereGilbert et alWe also used data from Follmann, Janes et al., who evaluated the kinetics of the antibody response to disease during the blinded phase of COVE, for supportive analysisA schematic of the two studies is given in Fig. 